REGISTRIES. Each Party shall be free to disclose any clinical trial Data generated by such Party concerning the Licensed Product as required by Applicable Law in clinical trial registries; provided, however, that the Party proposing to make such disclosure shall have provided the other Party at least ten (10) Business Days prior to such disclosure (to the extent practicable), a detailed description of the proposed disclosure and shall have, in good faith, considered the comments made by the other Party. 4.6.
Appears in 1 contract
Samples: Termination and Transfer Agreement (Cti Biopharma Corp)
REGISTRIES. Each Party shall be free to disclose any clinical trial Clinical Study Data generated by such Party concerning the a Licensed Product as required by Applicable Law in clinical trial registries; provided, however, that the Party proposing to make such disclosure shall have provided the other Party at least ten (10) [***] Business Days prior to such disclosure (to the extent practicable), a detailed description of the proposed disclosure and shall have, in good faith, considered the comments made by the other Party. 4.6.
Appears in 1 contract
Samples: Exclusive License and Collaboration Agreement (Allogene Therapeutics, Inc.)
REGISTRIES. Each Party shall be free to disclose any clinical trial Data generated by such Party concerning the Licensed Product as required by Applicable Law in clinical trial registries; provided, however, that the Party proposing to make such disclosure shall have provided the other Party at least ten (10) Business Days ** prior to such disclosure (to the extent practicable), a detailed description of the proposed disclosure and shall have, in good faith, considered the comments made by the other Party. 4.6.
Appears in 1 contract
Samples: Exclusive License and Collaboration Agreement (Cti Biopharma Corp)
REGISTRIES. Each Party shall be free to disclose any clinical trial Data generated by such Party concerning the Licensed Product as required by Applicable Law in clinical trial registries; provided, however, that the Party proposing to make such Confidential Treatment Requested disclosure shall have provided the other Party at least ten (10) Business Days ** prior to such disclosure (to the extent practicable), a detailed description of the proposed disclosure and shall have, in good faith, considered the comments made by the other Party. 4.6.
Appears in 1 contract
Samples: Exclusive License and Collaboration Agreement (Cti Biopharma Corp)
